The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.
| Product Specifications | |
| Application | FC |
| Reactivity | Human |
| Conjugation | PE |
| Immunogen | HLA-A*24:02 PBF145-153-AYRPVSRNI |
| Class | others |
| Formulation | 0.5 mM EDTA, 0.2% BSA, 10 mM Tris-HCl (pH 8.0), 200 mM NaCl, and 0.09% NaN3. |
| Storage | |
| Documents & Links for Human TCR Tetramer-PE (HLA-A*24:02 PBF145-153-AYRPVSRNI) | |
| Datasheet | Human TCR Tetramer-PE (HLA-A*24:02 PBF145-153-AYRPVSRNI) Datasheet |
| Documents & Links for Human TCR Tetramer-PE (HLA-A*24:02 PBF145-153-AYRPVSRNI) | |
| Datasheet | Human TCR Tetramer-PE (HLA-A*24:02 PBF145-153-AYRPVSRNI) Datasheet |
